Development, monitoring and first immunological results of a phase I/II vaccination trial using genetically modified allogeneic breast cancer cells

• Meuer S,
• Autschbach F,
• Huober J,
• Marmé A,
• Gruber I,
• Kayser S,
• Rentzsch C,
• Stumm S,
• Gückel B,
• Wallwiener D

Affiliations

Meuer S

Autschbach F

Huober J

Marmé A

Gruber I

Kayser S

Rentzsch C

Stumm S

Gückel B

Wallwiener D